Prognostic factors for survival outcome after in-hospital cardiac arrest: An observational study of the oriental population in Taiwan

Journal of the Chinese Medical Association : JCMA
Chung-Ting ChenMu-Shun Huang

Abstract

In-hospital cardiac arrest (IHCA) is a catastrophic complication for patients while admitted in a medical institution. The outcome of IHCA remains poor, and understanding of the prognostic factors for survival outcome after IHCA is lacking, specifically in an oriental population. A retrospective observational cohort study of 382 patients with IHCA who required resuscitation was conducted in an urban tertiary hospital in Taiwan. Return of spontaneous circulation (ROSC) and survival to hospital discharge were the primary outcome measures. The incidence of IHCA was 3.25 per 1000 admissions. These patients had a mean age of 67.2 ± 21.7 years and were mostly men (66.5%). The rate of successful ROSC was 66%, and the rate of survival to hospital discharge was 11.8%. A stepwise decrease in ROSC was observed with additional resuscitation efforts. Independent predictors for survival to hospital discharge were being female, a resuscitation duration of <20 minutes, and no use of epinephrine during resuscitation. A 68% ROSC success rate and an 84% survival to discharge rate was recorded in patients receiving resuscitation for <30 minutes. Young patients seemed the most likely to benefit from longer resuscitation attempts (>30 minutes), as o...Continue Reading

References

Feb 23, 1990·JAMA : the Journal of the American Medical Association·N A ParadisR M Nowak
Nov 1, 1996·Resuscitation·S C SchultzS R Evans
Sep 16, 1999·The New England Journal of Medicine·P J KudenchukT Walsh
Apr 26, 2001·The New England Journal of Medicine·M S Eisenberg, T J Mengert
Aug 25, 2001·The New England Journal of Medicine·P Safar
Dec 6, 2005·Resuscitation·Simon CooperGlenda Cooper
Jan 5, 2006·JAMA : the Journal of the American Medical Association·Vinay M NadkarniUNKNOWN National Registry of Cardiopulmonary Resuscitation Investigators
Oct 5, 2006·Intensive Care Medicine·Claudio SandroniMassimo Antonelli
Oct 3, 2007·Journal of the Chinese Medical Association : JCMA·Sen-Kuang HouChen-Hsen Lee
Feb 21, 2008·JAMA : the Journal of the American Medical Association·Mary Ann PeberdyUNKNOWN National Registry of Cardiopulmonary Resuscitation Investigators
Sep 17, 2009·JAMA : the Journal of the American Medical Association·Paul S ChanUNKNOWN American Heart Association National Registry of Cardiopulmonary Resuscitation (NRCPR) Investigators
Jun 28, 2011·Critical Care Medicine·Raina M MerchantUNKNOWN American Heart Association Get With The Guidelines-Resuscitation Investigators
Sep 11, 2012·Lancet·Zachary D GoldbergerUNKNOWN American Heart Association Get With The Guidelines—Resuscitation (formerly National Registry of Cardiopulmonary Resuscitati
Nov 16, 2012·The New England Journal of Medicine·Saket GirotraUNKNOWN American Heart Association Get with the Guidelines–Resuscitation Investigators
May 22, 2013·JAMA Internal Medicine·Lena M ChenUNKNOWN American Heart Association’s Get With the Guidelines-Resuscitation (formerly the National Registry of Cardiopulmonary Resusc
Jun 19, 2013·Journal of the American College of Cardiology·Paul S ChanUNKNOWN AHA GWTG-Resuscitation Investigators
Apr 26, 2014·The American Journal of the Medical Sciences·Phani KantamineniAbhijit Duggal
May 3, 2014·Current Opinion in Critical Care·David FagnoulDaniel De Backer
May 23, 2014·BMJ : British Medical Journal·Michael W DonninoUNKNOWN American Heart Association’s Get With The Guidelines-Resuscitation Investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.